1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Nucleobindins: new trials by email Literature Review of Nucleobindins trials Research Report on Nucleobindins
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor Inarigivir soproxil, Nucleoside/nucleotide (NUC) analogue inhibitors - Hepatitis B, HBV | Phase 2 | Terminated | F-star Therapeutics, Inc. | 64 | 2019-06-18 | 2020-07-22 |
Hepatitis B (1) · Hepatitis B, Chronic (1)
Canada (1) · United Kingdom (1)
Don Mitchell (1)